05.01.2021 | Editorial
Mechanical dyssynchrony and super-response to CRT
verfasst von:
K. A. Jones, MSc, N. E. R. Goodfield, MBChB, MRCP
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 3/2022
Einloggen, um Zugang zu erhalten
Excerpt
Cardiac resynchronisation therapy (CRT) is a well-established and important treatment option for patients in heart failure, which improves survival, morbidity, and quality of life.
1‐
3 However, CRT is not an effective treatment for all patients and despite all the research that the selection criteria is based on,
4 approximately 30% of patients who undergo CRT therapy are classified as non-responders.
5 CRT is costly and not without risk; therefore, finding ways to predict responders to CRT is of clinical interest. …